agilon health (NYSE:AGL) Shares Down 6.7% – Time to Sell?

agilon health, inc. (NYSE:AGL)’s stock price dropped 6.7% on Wednesday . The stock traded as low as $1.94 and last traded at $1.96. Approximately 500,424 shares were traded during trading, a decline of 90% from the average daily volume of 4,854,712 shares. The stock had previously closed at $2.10.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on AGL. Evercore ISI decreased their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Sanford C. Bernstein assumed coverage on shares of agilon health in a report on Wednesday. They set a “market perform” rating and a $2.50 price target for the company. William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Royal Bank of Canada reiterated an “outperform” rating and issued a $3.00 target price on shares of agilon health in a research report on Tuesday, November 19th. Finally, JMP Securities cut shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Three investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, agilon health presently has a consensus rating of “Hold” and a consensus target price of $4.38.

agilon health Stock Down 1.6 %

The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The stock’s 50 day moving average price is $2.46 and its two-hundred day moving average price is $4.42.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the prior year, the firm earned ($0.06) EPS. As a group, analysts anticipate that agilon health, inc. will post -0.52 EPS for the current year.

Insider Buying and Selling

In other news, Director John William Wulf bought 45,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, with a total value of $98,100.00. Following the completion of the transaction, the director now directly owns 206,133 shares in the company, valued at $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Diana Mckenzie acquired 12,500 shares of agilon health stock in a transaction on Monday, November 25th. The stock was purchased at an average price of $2.28 per share, with a total value of $28,500.00. Following the transaction, the director now directly owns 51,319 shares in the company, valued at approximately $117,007.32. This trade represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 65,000 shares of company stock valued at $143,100. 3.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On agilon health

Several hedge funds and other institutional investors have recently modified their holdings of AGL. Point72 Asia Singapore Pte. Ltd. bought a new stake in agilon health during the 3rd quarter worth approximately $28,000. CWM LLC raised its holdings in shares of agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after buying an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC bought a new position in shares of agilon health in the second quarter valued at about $60,000. Allspring Global Investments Holdings LLC lifted its position in agilon health by 17,790.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock worth $70,000 after buying an additional 10,674 shares in the last quarter. Finally, Pallas Capital Advisors LLC bought a new stake in agilon health during the 2nd quarter worth about $77,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.